TrialBlood advances2023

Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.

Carol Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.